in 2022 found that tirzepatide did not cause duodenal ulcers in any participants, unlike dulaglutide 64
After being thoroughly briefed on the study's objectives, procedures, and potential risks, all participants were informed and consented
Distinguish between adjustment and genuine problems
When yellow bar is full and not moving the injection is complete
Patients should be aware of symptoms such as right upper quadrant pain, fever, or jaundice, which require prompt medical attention
Each provides a different piece of the puzzle, and together they paint a picture that is concerning enough to warrant attention but not alarming enough to discourage GLP-1 medication use entirely